New benchmark FDARxBench tests LLM regulatory and clinical reasoning

Researchers have developed FDARxBench, a new benchmark designed to evaluate the regulatory and clinical reasoning capabilities of large language models when processing complex FDA drug label documents. The benchmark, curated by experts in collaboration with FDA regulatory assessors, includes tasks for factual recall, multi-hop reasoning, and safe refusal behavior. Initial experiments indicate that current models exhibit significant limitations in factual grounding, long-context retrieval, and appropriate refusal, highlighting the need for improved LLM performance in regulatory-grade document comprehension. AI

IMPACT This benchmark will drive improvements in LLM accuracy and safety for regulatory and clinical document analysis.

RANK_REASON The cluster contains a research paper introducing a new benchmark for evaluating LLM capabilities. [lever_c_demoted from research: ic=1 ai=1.0]

Read on arXiv cs.AI →

• alphaXiv
• arXiv
• Betty Xiong
• CatalyzeX
• DagsHub
• FDARxBench
• Gotit.pub
• Hugging Face
• ScienceCast
• United States Food and Drug Administration

• paper
• product

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →